Annovis Bio, Inc. (ANVS) › Weighted Average Diluted SharesAnnovis Bio, Inc. (ANVS) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 6.31M2021-12-31: 7.63M2022-12-31: 8.16M2023-12-31: 9.02M2024-12-31: 12.24M2025-12-31: 20.55M20.55M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3120.55M+68.0%2026-03-13From 2025-01-012024-12-3112.24M+35.6%2026-03-13From 2024-01-012023-12-319.02M+10.5%2025-03-21From 2023-01-012022-12-318.16M+7.0%2024-03-29From 2022-01-012021-12-317.63M+20.9%2023-03-31From 2021-01-012020-12-316.31M—2022-03-02From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)